Gene Editing market size reached USD 5.1 billion in 2021 and is expected to reach USD 19.17 billion by 2029, growing at a CAGR of 18 % during the forecast period.
Gene editing involves the insertion or replacement of genetic material known as DNA. New gene-editing technologies have been developed that increased the speed, ease, and accuracy of making changes to DNA cells. These technologies are beginning to be used for new approaches in a variety of fields, including research, medicine, agriculture, biotechnology, and pest control. Gene editing has shown good potential for the treatment of genetic diseases, infectious diseases, and cancer. An increase in private and public partnerships and technological advancements such as Clustered Regularly interspace Short Palindromic Repeats (CRISPR) are further fueling the growth of the Gene Editing market.
read more..